Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Search Results
3 results
Filters applied: . Clear all
Page 1
Combined KRAS-MAPK pathway inhibitors and HER2-directed drug conjugate is efficacious in pancreatic cancer.
Nat Commun. 2024 Mar 20;15(1):2503. doi: 10.1038/s41467-024-46811-w.
Nat Commun. 2024.
PMID: 38509064
Free PMC article.
Intratumoral T-cell receptor repertoire composition predicts overall survival in patients with pancreatic ductal adenocarcinoma.
Pothuri VS, Hogg GD, Conant L, Borcherding N, James CA, Mudd J, Williams G, Seo YD, Hawkins WG, Pillarisetty VG, DeNardo DG, Fields RC.
Pothuri VS, et al.
Oncoimmunology. 2024 Mar 15;13(1):2320411. doi: 10.1080/2162402X.2024.2320411. eCollection 2024.
Oncoimmunology. 2024.
PMID: 38504847
Free PMC article.
Item in Clipboard
Pancreatic Cancer's PD1-Roadblock: When T-Cell Reinvigoration Is Not Enough.
Lander VE, DeNardo DG.
Lander VE, et al.
Clin Cancer Res. 2024 Feb 1;30(3):474-476. doi: 10.1158/1078-0432.CCR-23-2991.
Clin Cancer Res. 2024.
PMID: 38038687
Item in Clipboard
Cite
Cite